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Abstract A novel hydrogel, based on an alginate/hyalu-
ronate mixture and Ce(III) ions, with effective bioactive
and antimicrobial ability was developed to be used as
vehicle of a synthetic bone substitute producing an inject-
able substitute (IBS). Firstly, three different IBSs were
prepared using three developed alginate-based hydrogels,
the hydrogel Alg composed by alginate, the hydrogel
Alg/Ch composed by an alginate/chitosan mixture and the
hydrogel Alg/HA composed by an alginate/hyaluronate
mixture. MG63 cells viability on the IBSs was evaluated,
being observed a significantly higher cell viability on the
Alg/HA_IBS at all time points, which indicates a better cell
adaptation to the material, increasing their predisposition to
produce extracellular matrix and thus allowing a better
bone regeneration. Moreover, SEM analysis showed evi-
dent filopodia and a spreader shape of MG63 cells when
seeded on Alg/HA_IBS. This way, based upon the in vitro
results, the hydrogel Alg/HA was chosen to the in vivo
study by subcutaneous implantation in an animal model,
promoting a slight irritating tissue response and visible
tissue repairing. The next step was to grant antimicrobial
properties to the hydrogel that showed the best biological
behavior by incorporation of Ce(III) ions into the Alg/HA,
producing the hydrogel Alg/HA2. The antimicrobial activ-
ity of these hyaluronate-based hydrogels was evaluated
against Staphylococcus aureus, Staphylococcus epidermi-
dis, Pseudomonas aeruginosa and Candida albicans.
Results showed that Ce(III) ions can significantly enhance
the hydrogel antimicrobial ability without compromising
the osteoconductivity improvement promoted by the vehi-
cle association to the synthetic bone substitute.
1 Introduction
Bone defects regeneration remains a concern due to their
high incidence in people of different ages, limiting their
life quality. In the last few decades, synthetic bone sub-
stitutes have been developed in an attempt to solve this
medical challenge of bone regeneration [1, 2]. For instance,
glass-reinforced hydroxyapatite (GR-HA) composites are
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calcium phosphate-based substitutes able to chemically
mimic the bone inorganic phase. Their osteoconductive
behavior seems to create an ideal environment for bone
cells adhesion and proliferation, promoting bone regener-
ation [3–5].
Synthetic bone substitutes have been associated with
hydrogels in order to turn the substitutes injectable, what is
advantageous in some clinical applications that present
difficulties in the access to the bone defect, namely in the
augmentation of osteoporotic fractures, in some applica-
tions in the spine and in the treatment of maxillofacial
defects. Besides, this minimally invasive surgical approach
can decrease the surgery time and provides a faster and
more economic recovery of the patient [6, 7]. Moreover,
the hydrogel association can improve the osteoconductive
properties of the synthetic bone substitutes and even grant
them osteoinductive and osteogenic properties by the
incorporation of growth factors and stem cells within the
gel [8–12].
Natural polysaccharides are very promising molecules
for tissue engineering applications, since they present high
biocompatibility and resemble glycosaminoglycans of the
extracellular matrix (ECM). These polymers have shown a
lower stimulation of immunological reactions than some
synthetic polymers [13, 14]. Alginate is a natural biode-
gradable linear block co-polymer composed of two
monomers, b-D-mannuronic acid and a-L-guluronic acid,
which are linked by (1–4) glycosidic bonds. This natural
polysaccharide has been used to produce hydrogels by the
simple addition of divalent cations, such as Ca2?, which
bind to monomers carboxylic groups providing the cross-
linking of the polymeric chains and thus the gelation of the
alginate solution [15–17]. However, alginate has the bio-
medical disadvantage of presenting a lower cell adhesion
than other natural polymers by promoting a very low
protein adsorption and cell attachment due to its negative
charge and high hydrophilicity [18–20]. Thus, in order to
improve the cell adhesion on alginate, this polymer can be
easily associated with another polyelectrolyte that allows a
better cell adhesion.
Chitosan is a natural biodegradable polycation com-
posed by the monomers D-glucosamine and N-acetyl-D-
glucosamine linked by b(1–4)-glycosidic bond and it has
been used in biomedical applications as a promoter of cell
adhesion, proliferation and differentiation [13, 21, 22].
Hyaluronic acid is a natural biodegradable polyanion
composed by monomers D-glucuronic acid and N-acetyl-D-
glucosamine, linked by b(1–3) and b(1–4) glycosidic
bonds [23, 24]. This polymer is the main component of
ECM, being found in connective tissues and it is involved
in different biological processes, namely, in morphogene-
sis, wound repair, inflammation and metastasis, through the
interaction with cellular receptors [23, 25]. Hyaluronic acid
has also a strong potential in bone repair, since it is found
in high concentrations in the fracture callus, inhibiting the
osteoclasts differentiation and even participating in the
migration of mesenchymal stem cells [26–28].
In every surgical procedure there is the major risk of
infection that presents serious consequences, which can
compromise the recovery success. To prevent those
infections, several approaches have been tried, such as
sterility protocols and antibiotics administration. However,
these protocols are not always effective and the antibiotic
activity can even fail due to pathogenic resistance devel-
opment [29, 30]. Therefore, recently, studies were made to
ascertain the use of certain ions as antimicrobial agents,
such as cerium (Ce), which has revealed antimicrobial
properties against several microorganisms. This way, it can
be incorporated in different biomaterials to grant them
antimicrobial ability, contributing to a better implant per-
formance [31–33].
The purpose of this study was to evaluate the biological
performance in vitro and in vivo of three hydrogels pre-
viously developed based on alginate, chitosan and hyalu-
ronic acid, which should enhance the osteoconductive
properties of the bone substitute (GR-HA). Furthermore, in
order to obtain a hydrogel not only with an osteoconductive
ability but also with an antimicrobial ability to avoid
infections, Ce(III) ions were incorporated in one of these
hydrogels and its biological performance was also studied.
2 Materials and methods
2.1 Materials
Alginic acid sodium salt from brown algae (bioreagent
grade; low viscosity; 39 % of guluronic acid and 61 %
of mannuronic acid), hyaluronic acid sodium salt from
Streptococcus equi, calcium chloride hexahydrate (CaCl2
2H2O, medical grade) and cerium(III) nitrate hexahydrate
(Ce(NO3)36H2O) were purchased from Sigma (USA).
Chitosan HCl (medical grade) was purchased from Heppe
Medical Chitosan GmbH (Germany) and the hydroxyapa-




Three hydrogels were prepared according to the already
optimized protocol described in our previous work [34].
Briefly, an alginate hydrogel (Alg) was prepared by adding
a CaCl2 solution (15 9 10
3 mg/L) to a sodium alginate
solution (7 % (w/V)) in a proportion of 1:4 (VCaCl2:Vsodium
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alginate). An alginate/chitosan based hydrogel (Alg/Ch) was
prepared by adding a chitosan HCl solution (0.5 % (w/V))
to the CaCl2 solution, and then the alginate solution,
according to the proportions: 1:4 (VCaCl2:Vsodium alginate)
and 1:1 (Vchitosan HCl:Vsodium alginate). An alginate/hyaluro-
nate based hydrogel (Alg/HA) was prepared by adding a
sodium hyaluronate solution (0.5 % (w/V)) to the alginate
solution followed by the addition of the CaCl2 solution in
the proportions: 1:1 (Vsodium hyaluronate :Vsodium alginate) and
1:4 (VCaCl2:Vsodium alginate).
In addition, two other alginate/hyaluronate based
hydrogels with Ce(III) were prepared using cross-linking
solutions with different Ce(III) concentrations. One solu-
tion was prepared using 15 9 103 mg/L of CaCl2 and
6.6 9 102 mg/L of Ce(NO3)3 and other also using
15 9 103 mg/L of CaCl2, but with 13.2 9 10
2 mg/L of
Ce(NO3)3. Then, each solution was added, in a proportion
of 1:4 (Vcross-linking solution:Vsodium alginate), to the alginate/
hyaluronate mixture obtaining the hydrogel Alg/HA1 and
Alg/HA2, respectively.
2.2.2 Glass reinforced hydroxyapatite (GR-HA)
and injectable bone substitutes (IBSs) preparation
GR-HA was obtained by adding 2.5 % (w/w) of glass (with
the composition 65P2O5–15CaO–10CaF2–10Na2O, mol%)
to HAP mixed with microcrystalline cellulose. Then, discs
were prepared by uniaxial pressing and heat treated at
600 C to burn out the microcrystalline cellulose and then
sintered at 1,300 C for 1 h. Finally the discs were milled
and sieved to produce granules of a 500–1,000 lm size
range.
Five different IBSs were prepared by just mixing and
aggregating the GR-HA granules with each one of the
developed hydrogels, in the proportions that have already
been optimized in our previous work [34].
It should be noted that before the hydrogels preparation
the raw materials were appropriately sterilized. The sodium
alginate powder was sterilized in an autoclave (121 C for
15 min), after proving by FTIR–ATR (Fourier transform
infrared–attenuated total reflectance) spectroscopy analysis
that this method does not alter the polymer chemical
structure, and its solution was prepared under sterile con-
ditions. All the other polymeric solutions were filtered also
under sterile conditions and GR-HA granules were steril-
ized in an autoclave (121 C for 15 min).
2.2.3 Cell viability evaluation
2.2.3.1 Cell culture MG63 human osteosarcoma cells
were seeded in 75 cm2 flasks with 10 mL of a-MEM
(a-minimal essential medium, Gibco, USA), supplemented
with 10 % (V/V) of fetal bovine serum and 1 % (V/V)
antibiotic–antimycotic solution (PAA, Germany), in a
humidified atmosphere, with 5 % CO2, at 37 C. The cul-
ture medium was changed every 2 days.
2.2.3.2 MTT assay Firstly, 0.6 mL samples of each IBS
were placed on 24-well plates. Then, 1 mL of MG63 cell
suspension (2 9 104 cells/mL) was seeded on the surface
of each sample and the plates were incubated, at 37 C, in a
5 % CO2 humidified atmosphere, for different time periods
(24, 48 and 72 h). As comparative model, for the same
time points, wells with cells seeded on GR-HA granules
were used. Ethanol (96 % (V/V)) was added to wells with
cell suspension as null cell viability control, while simple
cell suspension was used as cell viability control.
After each incubation period, the cells viability was
measured using the MTT assay (3-[4,5-dimethyl-thiazol-
2-yl]-2,5-diphenyltetrazolium bromide, Sigma, USA)
according to the manufacture instructions. The absorbance
was measured at 565 nm (with a 630 nm background)
using the microplate reader STAT FAX 3200 (Awareness
Technology, USA). This experiment was performed in
triplicate for each IBS and GR-HA granules.
2.2.4 Scanning electron microscopy (SEM) analysis
The morphology of the osteoblastic human cells seeded on
the surface of Alg_IBS, Alg/Ch_IBS and Alg/HA_IBS, after
a contact period of 24 h, was analyzed by SEM. Briefly,
samples with cells were firstly fixed with 1.5 % (m/V)
glutaraldehyde in 0.14 M sodium cacodylate buffer (pH
7.4). Afterwards, samples were dehydrated using graded
ethanol solutions from 50 % (V/V) to 100 % (V/V), fol-
lowed by immersion in hexamethyldisilazanes (HMDS)
solutions ranging from 50 % (V/V) to 100 % (V/V). The
samples lasted 10 min in each ethanol and HMDS solution
and overnight in 100 % (V/V) HMDS. All used reagents
were purchased from Sigma (USA).
Finally, samples were placed onto aluminum stubs and
coated with gold/palladium using a sputter coater (SPI,
USA) for SEM analysis in a Quanta 400FEG SEM
microscope (FEI, USA).
2.2.5 Subcutaneous implantation in Sprague–Dawley
rats
All surgical procedures were performed with the approval
of the Veterinary Authorities of Portugal in accordance
with the European Communities Council Directive of
November 1986 (86/609/EEC). The hydrogel Alg/HA was
implanted in three adult male Sprague–Dawley rats
(Charles River, Spain) that were fed with standard chow
and water ad libitum. Adequate measures were taken to
minimize pain and discomfort taking into account human
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endpoints for animal suffering and distress. Animals were
housed for 2 weeks before entering the experiment. For
surgery, rats were placed in prone position under sterile
conditions and the skin from the clipped dorsal area
scrubbed in a routine fashion with antiseptic solution.
Anaesthesia was achieved with an intra-peritoneal injection
of a pre-mixed solution consisting in ketamine (Imalge`ne
1000), 100 mg/kg body weight (bw), and xylazyne
(Rompun), 200 mg/kg bw.
Four 1.5–2 cm long linear incisions were made on the
dorsal area. After dissection towards the ventral aspect of
the body, 1 mL of the tested hydrogel was subcutaneously
injected in one incision, one was left unfilled and served as
control (the skin and subcutaneous tissues were collected on
the surgery day), and the other two served as sham controls
(the incisions were performed and empty closed). Skin and
subcutaneous tissues were closed with a simple-interrupted
suture of a non-absorbable filament (Synthofil). An anti-
biotic (enrofloxacin, Alsir 2.5 %, 5 mg/kg bw, subcuta-
neously) was administered to prevent any infections.
2 weeks later, after performing the same anesthetic proto-
col, skin and subcutaneous tissues from the implant area and
sham incisions were collected and fixed in a container with
10 % formaldehyde solution for posterior histological
evaluation. The rats were then euthanized, by lethal intra-
cardiac injection of 5 % sodium pentobarbital (Euthasil).
Afterwards, tissues samples were routinely processed,
dehydrated, paraffin embedded, cut and stained with hae-
matoxylin and eosin (H&E). The cross-sections were then
examined by a pathologist and semi-quantitatively evalu-
ated according to International Standard (ISO 10993-6)
criteria for biological evaluation of the local effects of
medical devices after implantation. The objective is to
characterize the history and evolution of tissue response
after implantation of a medical device/biomaterial includ-
ing its final integration or degradation. The local effects are
evaluated by comparison of the tissue response caused by
the tested implant to that caused by the sample or sham
controls. The scoring system used for the histological
evaluation take into account the extent of the area affected;
the presence, number and distribution of polymorphonu-
clear cells, lymphocytes, plasma cells, macrophages and
giant cells; the presence, extent and type of necrosis; other
tissue changes such as neovascularization, fatty infiltration,
granuloma formation and bone formation and some mate-
rial parameters such as fragmentation and/or debris pres-
ence (Annex B of the ISO 10993-6).
2.2.6 Antimicrobial profile of the sodium hyaluronate-
based hydrogels
To evaluate the antimicrobial activity of hydrogels Alg/HA,
Alg/HA1 and Alg/HA2, four different microorganisms and
two different techniques were used. The antimicrobial
activity of the hydrogel Alg was used as null microbial
inhibition control.
2.2.6.1 Colony-forming units (CFU) count technique CFU
count technique was used for Staphylococcus aureus, Staph-
ylococcus epidermidis and Candida albicans in the presence
of the hydrogels Alg/HA, Alg/HA1 and Alg/HA2. Firstly,
50 lL of the microbial suspension (1.5 9 104 CFU/mL)
were spread onto a plate with solid growth medium (Liofil-
chem, Italy). Then, 2 mL of hydrogel was added and the plates
were incubated in aerobic conditions, at 37 C with 5 % CO2,
for 24 h. After incubation, standard CFU count of each plate
was done. This procedure was performed in quadruplicate for
each microorganism and for each hydrogel.
2.2.6.2 Inhibitory zone diameters technique This tech-
nique was used for Pseudomonas aeruginosa bacteria and
for this analysis 50 lL of the bacterial suspension
(1.5 9 108 CFU/mL) was spread onto the plates with solid
medium. Then, sterilized stainless-steel rings with an
external diameter of 1 mm (inner diameter, 7 mm) were
placed over and filled with 1 mL of sterilized hydrogel.
The plates were incubated in aerobic conditions, at 37 C
with 5 % CO2, for 24 h. After this period, the shortest
distance between the outer border of the ring and the first
point of bacterial growth was measured. This procedure
was performed in triplicate for each hydrogel.
2.2.7 Statistical analysis
Experimental data is presented as mean ± SD (standard
deviation). Statistical analysis of data was performed using
the one-way ANOVA test with Bonferroni post hoc anal-
ysis, using the software SigmaStat 3.5. The differences
were considered to be significant at a level of p \ 0.05.
3 Results and discussion
3.1 Cell viability evaluation
The viability of MG63 cells seeded on Alg_IBS, Alg/Ch_IBS,
Alg/HA_IBS and GR-HA granules was evaluated and com-
pared by the MTT assay where ethanol represents null cell
viability. MTT reduction can be generally attributed to
mitochondrial succinate dehydrogenase redox activity and
as such the results presented in Fig. 1 are proportional to cell
metabolism and therefore to cell viability [35].
As observed in Fig. 1, all the tested samples present a
cell metabolism increase with time and much higher values
than the ethanol control. At 24 h, the association of the
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hydrogels Alg/Ch and Alg/HA to GR-HA granules signifi-
cantly increases the cell viability on the substitute. How-
ever, at 48 and 72 h only the association of the hydrogel
Alg/HA to the GR-HA granules improves the cell viability
on the IBS. A higher viability can reveal a better cell
adaptation to the material, leading to a higher cell pro-
duction of ECM components and proliferation.
Cell growth and function are influenced by the bioma-
terial surface characteristics, such as morphology and/or
chemical composition. GR-HA is reported as presenting a
better osteoblastic growth and function than hydroxyapatite
(HAP), due to its triphasic composition: HAP, a- and b-
tricalcium phosphate (TCP). These two TCP crystal phases
are less stable than HAP, improving the osteoblasts per-
formance due to of ions release to the extra-cellular envi-
ronment [4, 5]. Moreover, the released ions react with
physiologic ions, leading to the formation of a new apatite
layer between the implant and bone, promoting the osteo-
integration [36].
The association of the hydrogels Alg/Ch and Alg/HA to
GR-HA can improve the cell viability due to their mor-
phology and chemical composition. The higher cell
metabolism using these two hydrogels, mainly the hydrogel
Alg/HA, can be explained by the addition of chitosan or
hyaluronate to alginate, thus enhancing the bioactive abil-
ity of the polymeric vehicle as expected. Chitosan and
hyaluronic acid are natural polysaccharides that have the
advantage of mimic ECM biological macromolecules,
which cells are naturally prepared to recognize and deal
with metabolically [13, 14].
3.2 SEM analysis
Cell attachment, adhesion and spreading are very important
steps for a good cell/material interaction. The way these
phenomena occur influences the cell’s ability to proliferate
and to differentiate, which is essential for the formation of
an implant/bone functional interface and the subsequent
biomaterial osteointegration. Therefore, SEM analysis was
performed in order to observe cell adhesion to the different
injectable systems as well as their morphology.
After 24 h of incubation, it is possible to observe that
MG63 cells adhered to the Alg_IBS, Alg/Ch_IBS and Alg/
HA_IBS surfaces, even though the cells present different
morphologies, as observed in Fig. 2a2–c2. The cells seeded
on the Alg_IBS surface have a spherical shape with some
visible lamellipodia. Two different cell adhesion stages can
be distinguished on the Alg/Ch_IBS surface, cells with a
spherical morphology and lamellipodia can be observed,
which indicate an initial stage of adhesion, and a more
advanced stage where the osteoblast-like cells have a
spread morphology and some filopodia. On the Alg/
HA_IBS surface, after just 1 day of incubation, cells have a
spreader shape with more developed filopodia.
The distinct cell morphology on the three IBSs can be
explained by the different cells/material interaction, which
is influenced by the implant surface properties [5, 37].
What mainly distinguishes the IBSs surfaces is the poly-
meric vehicle that is associated with the GR-HA. Thus, the
objective of improving the cell adhesion phenomenon on
the bone substitute by associating a bioactive polymer to an
alginate vehicle was successfully achieved, as expected
according to the literature [21, 38].
Chitosan structure resembles the glycosaminoglycans
of the bone extracellular matrix, and it has been reported
that it can act as a promoter of cell adhesion, mainly due
to its positively charged surface which will attract the
negatively charged cell surface [21, 22]. Hyaluronic acid
is the main component of the living tissues extracellular
matrix (ECM), namely in the connective tissue,
being involved in cell signaling and matrix organization
[23–25]. Its incorporation in the IBS allows it to mimic
the organic part of the bone ECM, while GR-HA mimics
the inorganic part of the tissue. This synergy can lead to a
better cell adhesion and spreading. This polymer is able to
interact with different cell surface receptors, establishing
several sites of adhesion between cells and the material
surface [39]. In a cell adhesion process, during the
establishment of the adhesion sites between cells and the
material surface, there is a specific degree of organization
and production of the cell cytoskeleton filamentous pro-
teins, namely of the actin filaments. They tend to
assemble in long bundles leading to protrusions (filopodia)
Fig. 1 Viability of MG63 cells seeded on the three developed IBSs,
after 24, 48 and 72 h of incubation. Data are presented as mean ± SD.
***p \ 0.001: significant difference between Alg/HA_IBS and each
one of the other samples. xxxp \ 0.001: significant difference between
Ethanol and each one of the other samples. #p \ 0.05: significant
difference of Alg/Ch_IBS compared with GR-HA and Alg_IBS
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of the plasma membrane, so the cells can stretch out on
the material surface, thus presenting a spreader shape [37,
40–42].
The cytoskeleton organization controls the cell mor-
phology, and once its proteins are involved in signal
transduction the cell shape can also be related with cell
growth and function [42, 43]. In fact, when cells try to
adhere to the surface of a material, mitochondrial activity
increases due to the energy production necessary to syn-
thesize the above-mentioned proteins that are crucial to cell
adhesion. Since MTT measure mitochondrial activity and
by extension cell viability, the process of cell adhesion is
close-related to cell viability [44]. In this work the Alg/
HA_IBS presented cells with the spreader and organized
structure and so it also presented the highest viability, as
discussed previously.
Fig. 2 SEM appearance of the MG63 cells adhered on the three developed IBSs after 24 h of incubation: A1-Alg_IBS non-cell seeded; A2-
Alg_IBS cell seeded; B1-Alg/Ch_IBS non-cell seeded; B2-Alg/Ch_IBS cell seeded; C1-Alg/HA_IBS non-cell-seeded; C2-Alg/HA_IBS cell seeded.
The arrows indicate cells adhered on the materials
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3.3 Subcutaneous implantation
After in vitro characterization, the Alg/AH hydrogel that
showed the best performance was evaluated by subcuta-
neous implantation in Sprague–Dawley rats, to assess the
tissue local biological response to this hydrogel.
Throughout 2 weeks follow-up time, all animals remained
healthy and none developed local or systemic signs of
infection and/or inflammation were observed. Using a
descriptive analysis and a scoring system according to
Standard ISO 10993-6, the following criteria were con-
sidered for semi-quantitative histological study of the
tissue around the implanted material: collagen fibers for-
mation, inflammatory infiltrate, the presence of necrosis
and other tissue alterations such as vascularization, lipid
infiltration.
To determine the biological response of the biomaterial,
the result of the control subcutaneous tissue (SC tissue (T0))
was first determined (5.0), as presented in Table 1. Then,
according to the same evaluation method, the sham samples
(Sham 1 and Sham 2) were analyzed and the average of the
samples was estimated (27.57). In turn, the mean of these
two variables represents the value of the control to be
considered, in order to remove the inflammation grade that
rats usually present in their subcutaneous tissue and to
underestimate the effects of the surgical and suture tech-
niques (16.29). The tissue area around the hydrogel Alg/HA
(SC tissue (Alg/HA)) was also evaluated and the ISO score
determined (23.22). Finally, the sample biological response,
i.e. the inflammation caused only by the biomaterial, was
achieved by subtracting the value of the control to the value
of the SC tissue (Alg/HA) (6.93). By ISO 10993-6, this
result corresponds to a slight irritating response, thus
making this material biocompatible and adequate for
in vivo application.
The distinction between the various inflammatory cells
was performed in accordance with the classical morpho-
logical characteristics of each cell population where vari-
ous lymphocytes and plasma cells are visible in Fig. 3.
Such histological findings are in agreement with an attempt
at healing by connective tissue replacement of damaged
tissue, strengthened by the presence of macrophages since
these cells play a critical role in the initiation, maintenance
and resolution of inflammation. Quantitatively, Table 1
indicates the very low number of neutrophils and giant
cells (not seen in Fig. 3), and even the absence of necrosis
and lipid infiltration. Neovascularization and fibrosis are
clearly visible in Fig. 3, typical of tissue regeneration
process.
3.4 Antimicrobial profile of the sodium hyaluronate-
based hydrogels
Every surgical procedure, even a less invasive one, pre-
sents susceptibility to infections, which can compromise
the success of the implanted material. Several approaches
are used to prevent those infections, namely the use of
sterility protocols and the antibiotics administration.
However, those protocols are not always effective and the
use of antibiotics can induce bacterial resistance that
inhibits their effect [29, 30]. Thus, the use of a vehicle with
the ability to decrease or inhibit the growth of several
microorganisms could significantly improve the clinical
outcomes of the bone substitute usage [29, 45]. In order to
achieve that purpose, it was decided to incorporate in the
hydrogel ions with antimicrobial properties. Silver (Ag),
for instance, has already been reported as an effective
antibacterial agent, but it has also been reported as a
cytotoxic agent [46]. Ce(III) ions have also been reported
as having a bacteriostatic and bactericidal effect [31, 33].
Therefore, the hydrogel, that revealed the better bio-
logical performance in vitro and a good response in vivo,
was modified in an attempt to obtain a bioactive vehicle
also with potential antimicrobial properties. Thus, Ce(III)
ions were incorporated in hydrogel Alg/HA in two different
concentrations: Alg/HA1 and Alg/HA2.
In order to perform a deeper analysis, the sodium
hyaluronate-based hydrogels antimicrobial properties were
evaluated against the main bacteria responsible for infec-
tions in hospital environment, namely in orthopedic sur-
gical procedures, and even against the most prevalent
fungus [29, 45, 47, 48]. In order to determine the growth of
such microbes in the presence of each tested hydrogel, two
different techniques were used. S. aureus, S. epidermidis
Table 1 Results of the biological response to the implanted material,
according to ISO 10993-6
Cell type/response SC Tissue (Tu) Sham 1 Sham 2 SC Tissue
(Alg/HA)
Average
Neutrophilis 0.00 0.71 1.85 0.33
Lymphocytes 1.00 3.00 3.00 2.89
Plasma cells 0.33 2.85 3.00 2.33
Macrophages 0.57 3.00 2.85 3.89
Giant cells 0.00 1.71 0.57 0.11
Necrosis 0.00 0.43 0.00 0.00
Sub-total (92) 4.00 23.43 22.57 19.11
Neovascularization 1.00 2.57 3.00 2.78
Fibrosis 0.00 1.43 2.14 1.33
Lipid infiltration 0.00 0.00 0.00 0.00
Sub-total 1.00 4.00 5.14 4.11
Total 5.0 27.43 27.71 23.32
Sham average = (27.43 ? 27.21)/2 = 27.57. Control average = (27.57 ?
5.0)/2 = 16.29. Biological response of Alg/HA hydrogel = 23.22 -
15.29 = 6.93
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and C. albicans grow to form individual colonies, which
are countable. P. aeruginosa forms irregular spots, which
sometimes are overlapping, thus making the inhibitory
zone diameters technique more appropriate to use.
As presented in Fig. 4, the hydrogel Alg/HA shows
antimicrobial activity against all tested microorganisms
when compared with the hydrogel Alg (considered as null
antimicrobial activity control). These results indicate that
hyaluronic acid has an antimicrobial effect, which is in
accordance with the literature including the lower effect
against P. aeruginosa [45].
Hyaluronic acid has previously shown to have a wide
bacteriostatic effect, namely against microbes commonly
found in orthopaedic practice and oral cavity [45]. This
polymer can induce the expression of some innate immu-
nity antibiotic peptides, such as b-defensin 2 produced
by epithelial cells, which exhibits antimicrobial activity
[49, 50]. However, in this work it was tried to improve the
antimicrobial ability of the hydrogel even more, promoted
by the hyaluronic acid, by incorporating Ce(III) ions.
Regarding the Ce(III) antimicrobial ability, it is
observed in Fig. 4 that the addition of this ion enhanced
the antimicrobial activity of the hydrogel Alg/HA. For
S. aureus, S. epidermidis and C. albicans, hydrogel Alg/
HA1 presents a significant antimicrobial activity increase
compared to the hydrogel Alg/HA. A higher Ce(III) con-
centration in the hydrogel Alg/HA2, for these microor-
ganisms, leads to an even stronger activity. Concerning P.
aeruginosa, it is necessary to add to the hydrogel Alg/HA
the highest tested Ce(III) concentration to verify a signifi-
cant antibacterial effect increase. This bacterium higher
resistance to the ion, when comparing to others microor-
ganisms, has already been verified [32].
Cerium is reported as having bacteriostatic and bacteri-
cidal activity against several bacteria and also antimicrobial
effect against fungi [51]. Regarding its way of action, some
possible mechanisms have been postulated: the uptake of
cerium into the cytoplasm can inhibit the cellular respira-
tion, oxygen uptake and glucose metabolism, or eventually
the disruption of cell membrane [31, 32]. P. aeruginosa,
being a gram-negative bacterium, has a more complex cell
Fig. 3 Histological image of skin and subcutaneous tissues from the
implant area (SC tissue (Alg/HA)), after 2 weeks of the hydrogel Alg/
HA implantation; scale bar: 100 lm
Fig. 4 Antimicrobial activity of
the hydrogels Alg/HA, Alg/HA1
and Alg/HA2 after 24 h of
incubation. Values were
obtained using the hydrogel Alg
as model of null inhibition. Data
are presented as mean ± SD.
***p \ 0.001: significant
difference compared with
Alg/HA
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wall than the gram-positive bacteria (S. aureus and S. epi-
dermidis). Its cell wall is composed by a peptidoglycan
layer and a lipidic external membrane, being less permeable
and susceptible to biocides than the gram-positive bacteria.
Thus, the weaker effect of Ce(III) in this microbe can be
explained by the difficulty of Ce(III) to enter and interfere in
cellular events.
3.5 Cell viability evaluation on the Alg/HA2_IBS
The MTT assay was performed in order to evaluate if
Ce(III) incorporation in the hydrogel Alg/HA influences the
MG63 cells metabolism in contact with the IBS. Thus, the
cell viability on Alg/HA_IBS was compared with the one on
Alg/HA2_IBS, since the hydrogel Alg/HA2 presented the
highest antimicrobial activity for all tested microorganisms.
It is clear, in Fig. 5, that the cell viability promoted by
the Alg/HA_IBS and Alg/HA2_IBS increases over time.
Nevertheless, the Alg/HA2_IBS presents a slightly lower
viability than the Alg/HA_IBS at 24 and 72 h. Despite this
reduction, about 5.42 ± 0.28 % at 24 h and 5.14 ±
0.25 % at 72 h, cell metabolism on Alg/HA2_IBS is still
much higher than the one verified on GR-HA granules
alone. Therefore, by using Ce(III) ions it is possible to
obtain a hydrogel with an effective antimicrobial ability
without interfering with cells viability improvement, as
desired.
It has been reported that lanthanides do not penetrate
mammalian cell membranes as it happens with bacteria [32,
52]. Nevertheless, Ce(III) radius is very similar to the Ca2?
one, therefore, Ce(III) is able to interact with calcium-
dependent transmembrane signaling channels, by which can
interfere with intracellular events and cause a decrease in
the viability of osteoblasts [32, 52]. However, this Ce(III)
competition with Ca2? can also have advantages, namely
inhibitory effect on mast cells degranulation and histamine
release from both these cells and basophils, by interference
with a cell membrane ATPase pump [32, 52].
4 Conclusions
Firstly, it was verified that the hydrogel association to the
GR-HA granules can enhance the osteoblasts viability of the
bone substitute, mainly by the hydrogel Alg/HA. Besides, the
cell adhesion and morphology on the IBSs was influenced by
the polymeric composition of the associated hydrogel.
In vivo experiments showed that the hydrogel Alg/HA caused
a slightly irritating response indicating its biocompatibility,
thus making it useful in biomedical applications.
The association of hyaluronic acid with alginate
increased the antimicrobial effect against the tested
microorganisms. Moreover, Ce(III) addition to the hydro-
gel Alg/HA enhances its antimicrobial activity without
compromise the hydrogel cell viability.
Overall, these results show that the hydrogel Alg/HA2 is
a very promising vehicle to associate with a synthetic bone
substitute. This hydrogel, besides allowing the granules
injection, also enhances the osteoconductive ability of the
substitute and even grant it an antimicrobial activity
improving its regenerative performance.
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